SlideShare a Scribd company logo
1 of 26
PHARMACOKINETICS - BASIC
CONSIDERATIONS PLASMA DRUG
CONCENTRATION ‐TIME PROFILE PLOTTING
DATA
HARVINDARSINGH , M.PHARM., 1st YEAR
SCHOOL OF PHARMACEUTICAL SCIENCE
IFTMUNIVERSITYMORADABAD
INTRODUCTION TO PHARMACOKINETICS
• The duration of a drug therapy ranges from a single dose of a
drug taken for relieving an acute condition such as headache to
drugs taken life –long for chronic conditions such as
hypertension, diabetes, asthma or epilepsy.
• The frequency of administration of a drug in a particular dose is
called as Dosage regimen.
• Depending upon the therapeutic objective to be attained, the
duration of drug therapy and the dosage regimen are decided.
Rational and optimal therapy with a drug depend upon‐
1. Choice of a suitable drug, and
2. Balance between the therapeutic and the toxic‐effects.
• Both, the therapeutic and the toxic effects, depend upon the
concentration of drug at the site of action which is difficult to
measure. However, it corresponds to a specific concentration of
drug in plasma which can be measured with accuracy.
•The drug fails to elicit a therapeutic response when the
concentration is below the effective level and precipitates adverse
reactions when above the toxic level. The plasma drug
concentration between these two limits is called as the
Therapeutic concentration range or Therapeutic window.
•The ratio of maximum safe concentration to minimum effective
concentration of the drug is called as the therapeutic index.
• Thus, in order to achieve therapeutic success, plasma
concentration of the drug should be maintained within the
therapeutic window. For this, knowledge is needed not only of the
mechanisms of drug absorption,
distribution, metabolism and excretion, but also of the kinetics of
these processes i.e. Pharmacokinetics.
DEFINITIONS:
Pharmacokinetics is defined as the kinetics of drug absorption,
distribution, metabolism and excretion (KADME) and their
relationship with the pharmacological, therapeutic or toxicological
response in humans.
• Absorption is defined as the process of movement of
unchanged drug from the site of administration to systemic
circulation (or to the site of measurement i.e. plasma).
• Distribution is reversible transfer of a drug between the
blood and the extra vascular fluids and tissues.
• Elimination is the major process for removal of a drug from the
body and termination of its action. It is defined as the irreversible
loss of drug from the body. Elimination occurs by two processes
viz. biotransformation and excretion.
• Metabolism (Biotransformation) of drugs is defined as the
chemical conversion of one form to another.
• Excretion is defined as the process whereby drugs and/or their
metabolites are irreversibly transferred from internal to external
environment.
PHARMACOKINETIC STUDIES:
There are two aspects of pharmacokinetic studies‐
1.Theoretical aspect: which involves development of
pharmacokinetic models to predict drug disposition after its
administration. Statistical methods are commonly applied to
interpret data and assess various parameters.
2. Experimental aspect: which involves development of biological
sampling techniques, analytical methods for measurement of drug
(and metabolites) concentration in biological samples and data
collection and evaluation.
Several relevant terms:
Clinical Pharmacokinetics is defined as the application of
pharma -------cokinetic principles in the safe and effective
management of individual patient.
Population Pharmacokinetics is defined as the study of
Pharma ----cokinetic differences of drugs in various population
groups.
Toxicokinetics is defined as the application of pharmacokinetic
principles to the design, conduct and interpretation of drug safety
evaluation studies.
PLASMA DRUG CONCENTRATION –TIME
PROFILE :
A direct relationship exists between the concentration of drug at
the biophase (site of action) and the concentration of drug in
plasma. Two categories of parameters can be evaluated from a
plasma concentration time profile –
.pharmacokinetic parameters, and
.Pharmacodynamic parameters.
A typical plasma drug concentration ‐time curve obtained after a
single oral dose of a drug and showing various pharmacokinetic
and pharmacodynamics parameters is depicted in figure. Such a
profile can be obtained by measuring concentration of drug in
plasma samples taken at various intervals of time after
administration of a dosage form and plotting the concentration of
drug in plasma (Y‐axis) versus the corresponding time at which the
plasma sample was collected at (x-axis).
PHARMACOKINETIC PARAMETERS:
The three important pharmacokinetic parameters that
describe the plasma level‐time curve and useful in
assessing the bioavailability of a drug from its formulation
are‐
1. Peak Plasma concentration (Cmax): The point of
maximum concentration of drug in plasma is called as the
peak and the concentration of drug at peak is known as
peak plasma concentration.
It is also called as peak height concentration and maximum
drug concentration. Cmax is expressed in mcg/ml.
The peak level depends upon-
ƒDose administered
ƒRate of absorption, and
ƒRate of elimination.
The peak represents the point of time when absorption rate equals
elimination rate of drug. The portion of curve to the left of peak
represents absorption phase i.e. when the rate of absorption is
greater than the rate of elimination. The section of curve to the
right of peak generally represents elimination phase i.e. when the
rate of elimination exceeds rate of absorption. Peak concentration
is often related to the intensity of pharmacological response and
should ideally be above minimum effectiveconcentration (MEC)
but less than the minimum safe concentration (MSC).
2.Time of peak concentration (tmax):
The time for drug to reach peak concentration in plasma
(after extravascular administration) is called as the time of
peak concentration.
It is expressed in hours and is useful in estimating the rate
of absorptions.
Onset time and onset of action are dependent upon the
parameter is of particular importance in assessing the
efficacy of drug used to treat acute conditions like pain and
insomnia which can be treated by a single dose.
3.Area under the curve:
It represents the total integrated area under the plasma
level‐time profile and expresses the total amount of drug that
comes into the systemic circulation after its administration.
AUC is expressed in mcg/ml * hours. It is the most important
parameter in evaluating the bioavailability of a drug from its
dosage form as it represents the extent of absorption.
AUC is also important for drugs that are administered
repetitively for the treatment of chronic conditions like asthma
or epilepsy.
PHARMACODYNEMIC PARAMETERS:
The various Pharmacodynamic parameters are‐
1. Minimum Effective Concentration (MEC): It is defined as the
minimum concentration of drug in plasma required to produce the
therapeutic effect.
It reflects the minimum concentration of drug at the receptor site
to elicit the desired pharmacological response.
The concentration of drug below MEC is said to be in the
sub‐therapeutic level. In case of antibiotics, the term minimum
inhibitory concentration (MIC) is used. It describes the minimum
concentration of antibiotic in plasma required to kill or inhibit the
growth of micro organisms .
2.Maximum safe concentration (msc):
Also called as minimum toxic concentration (MTC)
It is the concentration of drug in plasma above which adverse or
unwanted effects are precipitated. Concentration of drug above
MSC is said to be in the toxic level.
3. Onset of Action: The beginning of pharmacological
response is called as onset of action . It occurs when the
plasma drug concentration just exceeds the required MEC.
4. Onset Time: It is the time required for the drug to start
producing pharmacological response. It corresponds to the time
for the plasma concentration.
5. Duration of Action:
The time period for which the plasma concentration of drug
remains above the MEC level is called as duration of drug
action.
It is also defined as the difference between onset time and
time for the drug to decline back to MEC.
6. Intensity of Action :
It is the maximum pharmacological response produced by
the peak plasma concentration of drug. It is also called as
peak response.
7. Therapeutic Range :
The drug concentration between MEC and MSC represents the
therapeutic range.
It is Also known as therapeutic window.
8. Therapeutic Index :
The ratio of MSC to MEC is called as therapeutic index. It is also
defined as the ratio of dose required to produce toxic or lethal
effects to dose required to produce therapeutic effect.
The rate, velocity or speed of a reaction is given by ± (dc/dt). Here
dc is the small change in the concentration within a given time
interval dt.
Order of a reaction is defined as the number of concentration terms
on which the rate of a reaction depends when determined
experimentally.
RATE AND ORDER:
• Reaction rate is the speed at which a reaction takes place.
• It is “how quickly” a product is formed in a chemical
reaction.
Example Mg + Cl2 MgCl2
• In the case of multiple step reactions the
• slowest step determines the rate of reaction.
RATE OF REACTION:
Zero order reaction is defined as a reaction in which the rate
does not depend on the concentration terms of the reactants.
This is mathematically expressed as:
Where k0 is the specific rate constant for a zero order.
ZERO ORDER REACTION:
First order reaction is defined as a reaction in which the rate of
reaction depends on the concentration of one reactant.
Mathematically, the first order rate equation can be written as:
 Where c is the concentration of the reactant and k1 is the specific
rate constant for first order
FIRST ORDER REACTION:
Second order reaction is defined as a reaction in which the rate depends
on the concentration terms of two reactants each raised to the power
one. Consider the following reaction.
 The rate equation can be written as
Where [A] and [B] are the concentration of A and B, respectively, and k2
is the specific rate constant for second order. In other words, the rate of
reaction is first order with respect to A, and again first order with respect
to B. So the overall order of this reaction is second order
SECOND ORDER REACTION:
THANK YOU

More Related Content

What's hot

Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Nausheen Fatima
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokineticsAnand Addagalla
 
Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...
Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...
Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...Ronald Magbitang
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003Patel Parth
 
Pharmacokinetics and Pharmacodynamics
Pharmacokinetics and PharmacodynamicsPharmacokinetics and Pharmacodynamics
Pharmacokinetics and PharmacodynamicsBhaswat Chakraborty
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment ModellingPallavi Kurra
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationmohamed sanooz
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug MonitoringTulasi Raman
 
Pharmacokinetics and dynamics
Pharmacokinetics and dynamicsPharmacokinetics and dynamics
Pharmacokinetics and dynamicsAntara Banerji
 
Importance of clinical pharmacokinetic studies
Importance of clinical pharmacokinetic studiesImportance of clinical pharmacokinetic studies
Importance of clinical pharmacokinetic studiesJohn Douglas
 
Expt. 13 Calculation of pharmacokinetic parameters from a given data
Expt. 13 Calculation of pharmacokinetic parameters from a given dataExpt. 13 Calculation of pharmacokinetic parameters from a given data
Expt. 13 Calculation of pharmacokinetic parameters from a given dataVISHALJADHAV100
 
Unc slides on computational toxicology
Unc slides on computational toxicologyUnc slides on computational toxicology
Unc slides on computational toxicologySean Ekins
 
Pharmacokinetics model by shubham soni
Pharmacokinetics model by shubham soniPharmacokinetics model by shubham soni
Pharmacokinetics model by shubham soniShubham kumar Soni
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]BADAR UDDIN UMAR
 

What's hot (20)

Tdm technologies
Tdm technologiesTdm technologies
Tdm technologies
 
Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
 
Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...
Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...
Basic Intravenous Therapy 2: Pharmacology, Rational Therapy, Pharmacodynamics...
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003
 
Pharmacokinetics and Pharmacodynamics
Pharmacokinetics and PharmacodynamicsPharmacokinetics and Pharmacodynamics
Pharmacokinetics and Pharmacodynamics
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics ppt
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of elimination
 
Drug levels in blood
Drug levels in blood Drug levels in blood
Drug levels in blood
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
Pharmacokinetics and dynamics
Pharmacokinetics and dynamicsPharmacokinetics and dynamics
Pharmacokinetics and dynamics
 
1.pharmacokinetics
1.pharmacokinetics1.pharmacokinetics
1.pharmacokinetics
 
Importance of clinical pharmacokinetic studies
Importance of clinical pharmacokinetic studiesImportance of clinical pharmacokinetic studies
Importance of clinical pharmacokinetic studies
 
Expt. 13 Calculation of pharmacokinetic parameters from a given data
Expt. 13 Calculation of pharmacokinetic parameters from a given dataExpt. 13 Calculation of pharmacokinetic parameters from a given data
Expt. 13 Calculation of pharmacokinetic parameters from a given data
 
Unc slides on computational toxicology
Unc slides on computational toxicologyUnc slides on computational toxicology
Unc slides on computational toxicology
 
Pharmacokinetics model by shubham soni
Pharmacokinetics model by shubham soniPharmacokinetics model by shubham soni
Pharmacokinetics model by shubham soni
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
 

Similar to Harvindar singh

Pharmacokinetics basics Introduced and applications
Pharmacokinetics basics Introduced  and applicationsPharmacokinetics basics Introduced  and applications
Pharmacokinetics basics Introduced and applicationsSumant Saini
 
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptbasicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptTohfatulJinan1
 
Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfAshwin Saxena
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modellingPriyankaDabirBharadk
 
INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...
INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...
INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...krishna keerthi
 
S01-Introduction-to-PK.pptx
S01-Introduction-to-PK.pptxS01-Introduction-to-PK.pptx
S01-Introduction-to-PK.pptxWiamKhalil1
 
BP 604T unit 3 notes.docx
BP 604T unit 3 notes.docxBP 604T unit 3 notes.docx
BP 604T unit 3 notes.docxAlka Maral
 
Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...Nani Karnam Vinayakam
 
Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...Malla Reddy College of Pharmacy
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacyemebetnigatu1
 
Basic Introduction of ADME.
Basic Introduction of ADME.Basic Introduction of ADME.
Basic Introduction of ADME.shailu12980
 
Bioavailability and bioequivalence of Drug Product.docx
Bioavailability and bioequivalence of Drug Product.docxBioavailability and bioequivalence of Drug Product.docx
Bioavailability and bioequivalence of Drug Product.docxabhisheksinghcompute
 
Introduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenIntroduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenKLE College of pharmacy
 
Introduction to biopharmaceutics (Part:01)
Introduction to biopharmaceutics (Part:01)Introduction to biopharmaceutics (Part:01)
Introduction to biopharmaceutics (Part:01)MdNazmulIslamTanmoy
 
Therapeutic drug monitoring
Therapeutic  drug monitoringTherapeutic  drug monitoring
Therapeutic drug monitoringDr Sajeena Jose
 
LS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptx
LS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptxLS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptx
LS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptxDorenceSimuntala
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSDollySadrani
 

Similar to Harvindar singh (20)

Pharmacokinetics basics Introduced and applications
Pharmacokinetics basics Introduced  and applicationsPharmacokinetics basics Introduced  and applications
Pharmacokinetics basics Introduced and applications
 
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptbasicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
 
Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdf
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modelling
 
INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...
INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...
INTRODUCTION TO BIOPHARMACEUTICS , pharmacokinetics, pharmacodynamics and the...
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
S01-Introduction-to-PK.pptx
S01-Introduction-to-PK.pptxS01-Introduction-to-PK.pptx
S01-Introduction-to-PK.pptx
 
BP 604T unit 3 notes.docx
BP 604T unit 3 notes.docxBP 604T unit 3 notes.docx
BP 604T unit 3 notes.docx
 
Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...
 
Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
Basic Introduction of ADME.
Basic Introduction of ADME.Basic Introduction of ADME.
Basic Introduction of ADME.
 
Therapeutic drug monitoring
Therapeutic  drug monitoringTherapeutic  drug monitoring
Therapeutic drug monitoring
 
Bioavailability and bioequivalence of Drug Product.docx
Bioavailability and bioequivalence of Drug Product.docxBioavailability and bioequivalence of Drug Product.docx
Bioavailability and bioequivalence of Drug Product.docx
 
Introduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenIntroduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimen
 
Introduction to biopharmaceutics (Part:01)
Introduction to biopharmaceutics (Part:01)Introduction to biopharmaceutics (Part:01)
Introduction to biopharmaceutics (Part:01)
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Therapeutic drug monitoring
Therapeutic  drug monitoringTherapeutic  drug monitoring
Therapeutic drug monitoring
 
LS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptx
LS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptxLS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptx
LS 1.2- Introduction to Pharmacokinetics & Pharmacodynamics.pptx
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
 

More from Harevindarsingh

Challenges in formulating herbal cosmatics
Challenges in formulating herbal cosmaticsChallenges in formulating herbal cosmatics
Challenges in formulating herbal cosmaticsHarevindarsingh
 
Self micro emulsifying drug delivery system
Self micro emulsifying drug delivery systemSelf micro emulsifying drug delivery system
Self micro emulsifying drug delivery systemHarevindarsingh
 
Telepharmacy ppt to alka mam
Telepharmacy ppt to alka mamTelepharmacy ppt to alka mam
Telepharmacy ppt to alka mamHarevindarsingh
 
uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICS
 uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICS uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICS
uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICSHarevindarsingh
 
Assignment by harvindar from prashant sir
Assignment by harvindar from prashant sirAssignment by harvindar from prashant sir
Assignment by harvindar from prashant sirHarevindarsingh
 

More from Harevindarsingh (6)

Challenges in formulating herbal cosmatics
Challenges in formulating herbal cosmaticsChallenges in formulating herbal cosmatics
Challenges in formulating herbal cosmatics
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Self micro emulsifying drug delivery system
Self micro emulsifying drug delivery systemSelf micro emulsifying drug delivery system
Self micro emulsifying drug delivery system
 
Telepharmacy ppt to alka mam
Telepharmacy ppt to alka mamTelepharmacy ppt to alka mam
Telepharmacy ppt to alka mam
 
uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICS
 uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICS uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICS
uv spectroscopy by HARVINDAR SINGH .M.PHARM PHARMACEUTICS
 
Assignment by harvindar from prashant sir
Assignment by harvindar from prashant sirAssignment by harvindar from prashant sir
Assignment by harvindar from prashant sir
 

Recently uploaded

Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfSwapnil Therkar
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzohaibmir069
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PPRINCE C P
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRDelhi Call girls
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfWadeK3
 

Recently uploaded (20)

Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistan
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C P
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
 

Harvindar singh

  • 1. PHARMACOKINETICS - BASIC CONSIDERATIONS PLASMA DRUG CONCENTRATION ‐TIME PROFILE PLOTTING DATA HARVINDARSINGH , M.PHARM., 1st YEAR SCHOOL OF PHARMACEUTICAL SCIENCE IFTMUNIVERSITYMORADABAD
  • 2. INTRODUCTION TO PHARMACOKINETICS • The duration of a drug therapy ranges from a single dose of a drug taken for relieving an acute condition such as headache to drugs taken life –long for chronic conditions such as hypertension, diabetes, asthma or epilepsy. • The frequency of administration of a drug in a particular dose is called as Dosage regimen. • Depending upon the therapeutic objective to be attained, the duration of drug therapy and the dosage regimen are decided.
  • 3. Rational and optimal therapy with a drug depend upon‐ 1. Choice of a suitable drug, and 2. Balance between the therapeutic and the toxic‐effects. • Both, the therapeutic and the toxic effects, depend upon the concentration of drug at the site of action which is difficult to measure. However, it corresponds to a specific concentration of drug in plasma which can be measured with accuracy. •The drug fails to elicit a therapeutic response when the concentration is below the effective level and precipitates adverse reactions when above the toxic level. The plasma drug concentration between these two limits is called as the Therapeutic concentration range or Therapeutic window.
  • 4. •The ratio of maximum safe concentration to minimum effective concentration of the drug is called as the therapeutic index. • Thus, in order to achieve therapeutic success, plasma concentration of the drug should be maintained within the therapeutic window. For this, knowledge is needed not only of the mechanisms of drug absorption, distribution, metabolism and excretion, but also of the kinetics of these processes i.e. Pharmacokinetics.
  • 5. DEFINITIONS: Pharmacokinetics is defined as the kinetics of drug absorption, distribution, metabolism and excretion (KADME) and their relationship with the pharmacological, therapeutic or toxicological response in humans. • Absorption is defined as the process of movement of unchanged drug from the site of administration to systemic circulation (or to the site of measurement i.e. plasma). • Distribution is reversible transfer of a drug between the blood and the extra vascular fluids and tissues.
  • 6. • Elimination is the major process for removal of a drug from the body and termination of its action. It is defined as the irreversible loss of drug from the body. Elimination occurs by two processes viz. biotransformation and excretion. • Metabolism (Biotransformation) of drugs is defined as the chemical conversion of one form to another. • Excretion is defined as the process whereby drugs and/or their metabolites are irreversibly transferred from internal to external environment.
  • 7. PHARMACOKINETIC STUDIES: There are two aspects of pharmacokinetic studies‐ 1.Theoretical aspect: which involves development of pharmacokinetic models to predict drug disposition after its administration. Statistical methods are commonly applied to interpret data and assess various parameters. 2. Experimental aspect: which involves development of biological sampling techniques, analytical methods for measurement of drug (and metabolites) concentration in biological samples and data collection and evaluation.
  • 8. Several relevant terms: Clinical Pharmacokinetics is defined as the application of pharma -------cokinetic principles in the safe and effective management of individual patient. Population Pharmacokinetics is defined as the study of Pharma ----cokinetic differences of drugs in various population groups. Toxicokinetics is defined as the application of pharmacokinetic principles to the design, conduct and interpretation of drug safety evaluation studies.
  • 9. PLASMA DRUG CONCENTRATION –TIME PROFILE : A direct relationship exists between the concentration of drug at the biophase (site of action) and the concentration of drug in plasma. Two categories of parameters can be evaluated from a plasma concentration time profile – .pharmacokinetic parameters, and .Pharmacodynamic parameters.
  • 10. A typical plasma drug concentration ‐time curve obtained after a single oral dose of a drug and showing various pharmacokinetic and pharmacodynamics parameters is depicted in figure. Such a profile can be obtained by measuring concentration of drug in plasma samples taken at various intervals of time after administration of a dosage form and plotting the concentration of drug in plasma (Y‐axis) versus the corresponding time at which the plasma sample was collected at (x-axis).
  • 11.
  • 12. PHARMACOKINETIC PARAMETERS: The three important pharmacokinetic parameters that describe the plasma level‐time curve and useful in assessing the bioavailability of a drug from its formulation are‐ 1. Peak Plasma concentration (Cmax): The point of maximum concentration of drug in plasma is called as the peak and the concentration of drug at peak is known as peak plasma concentration. It is also called as peak height concentration and maximum drug concentration. Cmax is expressed in mcg/ml.
  • 13. The peak level depends upon- ƒDose administered ƒRate of absorption, and ƒRate of elimination. The peak represents the point of time when absorption rate equals elimination rate of drug. The portion of curve to the left of peak represents absorption phase i.e. when the rate of absorption is greater than the rate of elimination. The section of curve to the right of peak generally represents elimination phase i.e. when the rate of elimination exceeds rate of absorption. Peak concentration is often related to the intensity of pharmacological response and should ideally be above minimum effectiveconcentration (MEC) but less than the minimum safe concentration (MSC).
  • 14. 2.Time of peak concentration (tmax): The time for drug to reach peak concentration in plasma (after extravascular administration) is called as the time of peak concentration. It is expressed in hours and is useful in estimating the rate of absorptions. Onset time and onset of action are dependent upon the parameter is of particular importance in assessing the efficacy of drug used to treat acute conditions like pain and insomnia which can be treated by a single dose.
  • 15. 3.Area under the curve: It represents the total integrated area under the plasma level‐time profile and expresses the total amount of drug that comes into the systemic circulation after its administration. AUC is expressed in mcg/ml * hours. It is the most important parameter in evaluating the bioavailability of a drug from its dosage form as it represents the extent of absorption. AUC is also important for drugs that are administered repetitively for the treatment of chronic conditions like asthma or epilepsy.
  • 16. PHARMACODYNEMIC PARAMETERS: The various Pharmacodynamic parameters are‐ 1. Minimum Effective Concentration (MEC): It is defined as the minimum concentration of drug in plasma required to produce the therapeutic effect. It reflects the minimum concentration of drug at the receptor site to elicit the desired pharmacological response. The concentration of drug below MEC is said to be in the sub‐therapeutic level. In case of antibiotics, the term minimum inhibitory concentration (MIC) is used. It describes the minimum concentration of antibiotic in plasma required to kill or inhibit the growth of micro organisms .
  • 17. 2.Maximum safe concentration (msc): Also called as minimum toxic concentration (MTC) It is the concentration of drug in plasma above which adverse or unwanted effects are precipitated. Concentration of drug above MSC is said to be in the toxic level. 3. Onset of Action: The beginning of pharmacological response is called as onset of action . It occurs when the plasma drug concentration just exceeds the required MEC. 4. Onset Time: It is the time required for the drug to start producing pharmacological response. It corresponds to the time for the plasma concentration.
  • 18. 5. Duration of Action: The time period for which the plasma concentration of drug remains above the MEC level is called as duration of drug action. It is also defined as the difference between onset time and time for the drug to decline back to MEC. 6. Intensity of Action : It is the maximum pharmacological response produced by the peak plasma concentration of drug. It is also called as peak response.
  • 19. 7. Therapeutic Range : The drug concentration between MEC and MSC represents the therapeutic range. It is Also known as therapeutic window. 8. Therapeutic Index : The ratio of MSC to MEC is called as therapeutic index. It is also defined as the ratio of dose required to produce toxic or lethal effects to dose required to produce therapeutic effect.
  • 20. The rate, velocity or speed of a reaction is given by ± (dc/dt). Here dc is the small change in the concentration within a given time interval dt. Order of a reaction is defined as the number of concentration terms on which the rate of a reaction depends when determined experimentally. RATE AND ORDER:
  • 21. • Reaction rate is the speed at which a reaction takes place. • It is “how quickly” a product is formed in a chemical reaction. Example Mg + Cl2 MgCl2 • In the case of multiple step reactions the • slowest step determines the rate of reaction. RATE OF REACTION:
  • 22. Zero order reaction is defined as a reaction in which the rate does not depend on the concentration terms of the reactants. This is mathematically expressed as: Where k0 is the specific rate constant for a zero order. ZERO ORDER REACTION:
  • 23. First order reaction is defined as a reaction in which the rate of reaction depends on the concentration of one reactant. Mathematically, the first order rate equation can be written as:  Where c is the concentration of the reactant and k1 is the specific rate constant for first order FIRST ORDER REACTION:
  • 24. Second order reaction is defined as a reaction in which the rate depends on the concentration terms of two reactants each raised to the power one. Consider the following reaction.  The rate equation can be written as Where [A] and [B] are the concentration of A and B, respectively, and k2 is the specific rate constant for second order. In other words, the rate of reaction is first order with respect to A, and again first order with respect to B. So the overall order of this reaction is second order SECOND ORDER REACTION:
  • 25.